SMX CEO Gets 100K Vested RSUs as Equity Plan Expands — No Shareholder Vote
SMX sits 25% above its 52-week low of $12.51.
Summary
SMX amended its equity plan to add 110,000 shares and granted CEO Haggai Alon 100,000 immediately vested RSUs — a 9.2% stake — without a shareholder vote, deepening dilution concerns amid a going concern warning and zero revenue.
Key Events · Executive and Board Changes · SMX
-
Equity Plan Expanded Without Vote
The 2022 Incentive Equity Plan share pool was increased from ~671,641 to 781,641 shares — a 16% increase — without stockholder approval, relying on a Nasdaq foreign private issuer exemption.
-
CEO Granted 100K Vested RSUs
CEO Haggai Alon received 100,000 immediately vested restricted stock units, representing approximately 9.2% of the 1,088,608 outstanding shares as of July 23, 2026.
-
Consultant Also Gets 10K RSUs
An additional 10,000 immediately vested RSUs were granted to a consultant for services rendered, further diluting existing shareholders.
-
Six-Month Lock-Up on New Shares
The RSU grants carry a condition that the underlying shares cannot be registered for trading before January 22, 2027, preventing immediate selling but not reducing the dilution.
Analysis · SMX · Technology
Without seeking shareholder approval, SMX increased its incentive plan share pool by 16% and granted CEO Haggai Alon 100,000 immediately vested restricted stock units — roughly 9.2% of the current outstanding shares — relying on a Nasdaq foreign private issuer exemption. The RSUs cannot be registered for trading until January 22, 2027, creating a six-month lock-up. This follows a pattern of aggressive equity dilution: the company recently disclosed a going concern warning, zero revenue, and heavy reliance on SEPA draws. The grant effectively transfers significant ownership to the CEO at a time when the company is burning cash and issuing shares to stay afloat.
At the time of this filing, SMX was trading at $15.67 on NASDAQ in the Technology sector, with a market capitalization of approximately $10.2M. The 52-week trading range was $12.51 to $452,191.83. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.